December 2, 2010

XRL Vertebral Body Replacement

media-105758

The XRL Vertebral Body Replacement (VBR) implant is intended for use in the thoracolumbar spine (T1-L5) to replace a collapsed, damaged, or unstable vertebral body due to tumor or trauma (ie, fracture).

The XRL VBR has been designed to provide anterior spinal column support, even in the absence of fusion for a prolonged period. Due to the fact that its biomechanical characteristics (eg, modulus of elasticity) sit between the cancellous and cortical bone, the XRL VBR aids in stress distribution and load sharing. The implant is intended to be used with Synthes supplemental internal fixation systems (eg, USS, including MATRIX, Pangea, and TSLP).

The interior of the XRL VBR can be packed with bone (ie, autograft or allograft), and the PEEK implant's radiolucency gives surgeons the ability to assess tumor recurrence and fusion progress.

 

The implant encompasses modular endplates to accommodate multiple approach options. There are six endplate footprints that range from -10 to 20 degrees and construct heights that range from 22 to 145 mm, allowing the surgeon to customize the implant to better match patient anatomy.

An all-in-one spreader gives the surgeon the ability to insert, expand and lock implants all with one instrument.

Additionally, three solution options currently exist:

  • Allograft
  • Static VBRs in titanium and PEEK
  • Expandable VBRs in titanium and PEEK.

However, use of the XRL VBR implant is contraindicated when there is active systemic infection, infection localized to the site of the proposed implantation, or when the patient has demonstrated allergy or foreign body sensitivity to any of the implant materials. Severe osteoporosis may also prevent adequate fixation, and therefore preclude the use of this or any other orthopaedic implant.

Conditions that place excessive stresses on bones and implants, such as severe obesity or degenerative diseases, are relative contraindications. The decision whether to use this device with patients with such conditions must be made by the physician, taking into account the risks versus the benefits to the patient.

Use of the implants is also relatively contraindicated in patients whose activity, mental capacity, mental illness, alcoholism, drug abuse, occupation, or lifestyle interferes with their ability to follow postoperative restrictions, potentially placing undue stress on the implant during bone healing, resulting in a higher risk of implant failure.

media-105766

“approved by AO Technical Commission” and “approved by AO Foundation”
The brands and labels “approved by AO Technical Commission” and “approved by AO Foundation”, particularly "AO" and the AO logo, are AO Foundation's intellectual property and subject to trademark applications and registrations, respectively. The use of these brands and labels is regulated by licensing agreements between AO Foundation and the producers of innovation products obliged to use such labels to declare the products as AO Technical Commission or AO Foundation approved solutions. Any unauthorized or inadequate use of these trademarks may be subject to legal action.